Head-to-head trial aims to find best way to save sight in IIH patients
NCT ID NCT07440277
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two common procedures—CSF shunting and dural venous sinus stenting—to see which better preserves vision in adults with idiopathic intracranial hypertension (IIH) who are at risk of permanent sight loss. About 80 participants will be randomly assigned to one of the two procedures and followed for two years. The goal is to determine which treatment is more effective and cost-effective for saving vision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IIH - IDIOPATHIC INTRACRANIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Addenbrooke's Hospital
RECRUITINGCambridge, United Kingdom
-
Bristol Eye Hospital
NOT_YET_RECRUITINGBristol, United Kingdom
-
King's College Hospital
RECRUITINGLondon, United Kingdom
-
Leeds General Infirmary
RECRUITINGLeeds, United Kingdom
-
National Hospital for Neurology and Neurosurgery
RECRUITINGLondon, United Kingdom
-
Princess Alexandra Eye Pavillion
RECRUITINGEdinburgh, United Kingdom
-
Queen Elizabeth University Hospital
RECRUITINGGlasgow, United Kingdom
-
Queen's Medical Centre
RECRUITINGNottingham, United Kingdom
-
Royal Hull Infirmary
RECRUITINGHull, United Kingdom
-
Royal Victoria Infirmary
RECRUITINGNewcastle, United Kingdom
-
Southampton General Hospital
RECRUITINGSouthampton, United Kingdom
-
Southmead Hospital
NOT_YET_RECRUITINGBristol, United Kingdom
-
Sunderland Eye Infirmary
RECRUITINGSunderland, United Kingdom
-
The Queen Elizabeth Hospital
RECRUITINGBirmingham, United Kingdom
-
University Hospital of Wales
RECRUITINGCardiff, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.